183 related articles for article (PubMed ID: 38313799)
1. Editorial: Mechanisms of drug resistance to targeted therapy in malignancies.
Hamaji M
Front Oncol; 2024; 14():1363808. PubMed ID: 38313799
[No Abstract] [Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. [A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer].
Wang ZJ; Han YQ; Li Q; Mo HN; Li YQ; Guan XW; Chen YM; Lin SY; Xu BH; Li Q; Zhang P; Ma F
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):360-363. PubMed ID: 35448925
[No Abstract] [Full Text] [Related]
4. Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies.
Wu X; Yang H; Yu X; Qin JJ
Front Pharmacol; 2022; 13():1012552. PubMed ID: 36210846
[TBL] [Abstract][Full Text] [Related]
5. Clinical reversal of drug resistance.
Goldstein LJ
Curr Probl Cancer; 1995; 19(2):65-124. PubMed ID: 7600845
[TBL] [Abstract][Full Text] [Related]
6. CircRNA: A new class of targets for gastric cancer drug resistance therapy.
Zheng Y; Li Z; Wang Y; Chen W; Lin Y; Guo J; Ye G
Pathol Oncol Res; 2023; 29():1611033. PubMed ID: 37065861
[TBL] [Abstract][Full Text] [Related]
7. At the crossroads of cancer stem cells and targeted therapy resistance.
Wang A; Qu L; Wang L
Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
[TBL] [Abstract][Full Text] [Related]
8. Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy.
Wang W; Sun Y; Liu X; Kumar SK; Jin F; Dai Y
Front Oncol; 2022; 12():859455. PubMed ID: 35574302
[TBL] [Abstract][Full Text] [Related]
9. Reversal mechanism of multidrug-resistant cancer cells by lectin as chemo-adjuvant and targeted therapy- a systematic review.
Ghosh P; Patari N; Manisha C; Basavan D; Petchiappan V; Justin A
Phytomedicine; 2024 Jan; 123():155205. PubMed ID: 37980807
[TBL] [Abstract][Full Text] [Related]
10. The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients.
Prajoko YW; Aryandono T
Asian Pac J Cancer Prev; 2019 May; 20(5):1511-1518. PubMed ID: 31128056
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer stem cells and targeted therapy.
Keyvani V; Farshchian M; Esmaeili SA; Yari H; Moghbeli M; Nezhad SK; Abbaszadegan MR
J Ovarian Res; 2019 Dec; 12(1):120. PubMed ID: 31810474
[TBL] [Abstract][Full Text] [Related]
12. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.
Chen Z; Li Y; Tan B; Zhao Q; Fan L; Li F; Zhao X
Drugs Today (Barc); 2020 Jul; 56(7):469-482. PubMed ID: 32648857
[TBL] [Abstract][Full Text] [Related]
13. Guest editorial: efficacy of and resistance to molecularly targeted therapy for myeloid malignancies.
Kiyoi H
Int J Hematol; 2013 Jun; 97(6):681-2. PubMed ID: 23666667
[No Abstract] [Full Text] [Related]
14. The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine.
Li X; Li M; Huang M; Lin Q; Fang Q; Liu J; Chen X; Liu L; Zhan X; Shan H; Lu D; Li Q; Li Z; Zhu X
Biomed Pharmacother; 2022 Jun; 150():113064. PubMed ID: 35658234
[TBL] [Abstract][Full Text] [Related]
15. New strategy for overcoming resistance to chemotherapy of ovarian cancer.
Kigawa J
Yonago Acta Med; 2013 Jun; 56(2):43-50. PubMed ID: 24031151
[TBL] [Abstract][Full Text] [Related]
16. Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
Tortora G; Bianco R; Daniele G; Ciardiello F; McCubrey JA; Ricciardi MR; Ciuffreda L; Cognetti F; Tafuri A; Milella M
Drug Resist Updat; 2007 Jun; 10(3):81-100. PubMed ID: 17482503
[TBL] [Abstract][Full Text] [Related]
17. Role of YES1 signaling in tumor therapy resistance.
Zhou H; Sun D; Tao J; Xu M; Zhang X; Hou H
Cancer Innov; 2023 Jun; 2(3):210-218. PubMed ID: 38089407
[TBL] [Abstract][Full Text] [Related]
18. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
Front Oncol; 2021; 11():702082. PubMed ID: 34589423
[TBL] [Abstract][Full Text] [Related]
19. Therapy resistance mechanisms in hematological malignancies.
Hofmann WK; Trumpp A; Müller-Tidow C
Int J Cancer; 2023 Feb; 152(3):340-347. PubMed ID: 35962946
[TBL] [Abstract][Full Text] [Related]
20. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.
Wang Q; Shen X; Chen G; Du J
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
